BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.41 -0.19 (-5.28%)
At close: Oct 22, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Gains from Equity Investments (2024 - 2026)

Updated

Analysis

BriaCell Therapeutics (BCTX) Gains from Equity Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.75 Bn 1,113.34 Bn 19.71 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn
3 AbbVie 502.77 Bn 475.88 Bn 12.70 Bn
4 Merck 356.48 Bn 310.86 Bn 12.21 Bn
5 Novartis Ag 301.04 Bn 265.03 Bn 11.24 Bn
6 Astrazeneca 264.46 Bn 238.15 Bn 12.86 Bn
7 Amgen 238.99 Bn 194.39 Bn 7.24 Bn
8 Gilead Sciences 194.94 Bn 169.14 Bn 6.22 Bn
9 Pfizer 170.77 Bn 117.42 Bn 10.94 Bn
10 BriaCell Therapeutics 24.83 Mn -55.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -64,303.00
Jan 31, 2026 -61,993.00
Oct 31, 2025 -44,830.00
Jul 31, 2025 -47,375.00
Apr 30, 2025 -62,738.00
Jan 31, 2025 -42,584.00
Oct 31, 2024 -71,515.00
Jul 31, 2024 -51,168.00
Apr 30, 2024 -36,997.00
Jan 31, 2024 -18,345.00
API Access

BriaCell Therapeutics Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=BCTX&period=max&api_key=YOUR_API_KEY